NCRI 2018 | Modelling GBM: Improving the translation between preclinical data and effective treatments

In this interview, Anthony Chalmers, BM, BCh, FRCR, PhD, FRCP, from the University of Glasgow, Glasgow, UK, discusses the design and delivery of preclinical projects evaluating specific radiotherapy-drug combinations for glioblastoma (GBM). Speaking at the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Prof. Chalmers discusses approaches in trying to improve the survival rates seen in patients, focusing on future avenues for the improved modelling of GBM.